High Yield Production and Radiochemical Isolation of Isotopically Pure Arsenic-72 and Novel Radioarsenic Labeling Strategies for the Development of Theranostic Radiopharmaceuticals
Year: 2015
Type: article
Abstract: Radioisotopes of arsenic are of considerable interest to the field of nuclear medicine with unique nuclear and chemical properties making them well-suited for use in novel theranostic radiopharmaceuticals. However, progress must still be made in the production of isotopically pure radioarsenic and in its stable conjugation to biological targeting vectors. This work presents the production and irradiation of isotopically enriched (72)Ge(m) discs in an irrigation-cooled target system allowing for the production of isotopically pure (72)As with capability on the order of 10 GBq. A radiochemical separation procedure isolated the reactive trivalent radioarsenic in a small volume buffered aqueous solution, while reclaiming (72)Ge target material. The direct thiol-labeling of a monoclonal antibody resulted in a conjugate exhibiting exceptionally poor in vivo stability in a mouse model. This prompted further investigations to alternative radioarsenic labeling strategies, including the labeling of the dithiol-containing chelator dihydrolipoic acid, and thiol-modified mesoporous silica nanoparticles (MSN-SH). Radioarsenic-labeled MSN-SH showed exceptional in vivo stability toward dearsenylation.
Source: Bioconjugate Chemistry
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1712026730, G4004214011, ISOTOPE PRODUCTION SCALE-UP AT THE UNIVERSITY OF WISCONSIN-MADISON, Imaging Biomarkers for Combination Therapy of Prostate Cancer, TAS::89 0222::TAS; NEW; TITLE: MULTIMODALITY PLANT IMAGING USING SMALL PEPTIDE DERIVATIVES; PI: ONOFRE T. DEJESUS, Novel Combination Therapy for Prostate Cancer, UW Comprehensive Cancer Center Support, UW Radiological Sciences Training Program
OpenAlex ID: W2344482425
